الفهرس 
EpidemiologyOnly 14 pages are availabe for public view
 |  | from | 165 |  |  |
| | | from | 165 | | |
Abstract
Which favorably made angioplasty as a tempting first-choice treatment in CLI patients. However, other studies showed that bypass surgery resulted in better leg salvation survival than angioplasty.
Our multiple analysis results showed that there are no differences in leg salvation survival, revascularization, and long term mortality between these two groups. However, the mortality rate within 30 days was lower in angioplasty group than in bypass group. Also, angioplasty was non-inferior to bypass surgery in regarding the amputation free survival, revascularization, leg amputation and overall mortality. In contrast, angioplasty was a safer, simpler, and less invasive procedure with less cost, compared to bypass surgery. Based on these results, it is suggested that angioplasty should be considered as the first choice for feasible CLI patients.
Relatively recently, two decision-making guidelines have been developed for these revascularization options. The first is the TASC guidelines, which were developed in 2000 by the Trans-Atlantic Inter-Society Consensus for the management of Peripheral Arterial Disease (TASC). The TASC guidelines document was authored by a working group of representatives from 14 surgical, vascular, cardiovascular, and radiologic societies.
The TASC working group classified patients according to the anatomic patterns of disease involvement — types A through D (Figure 21). Based on their recommendations, TASC type A lesions are best treated with angioplasty and TASC type D lesions with bypass surgery. There was insufficient evidence concerning TASC type B and C lesions to definitively recommend one modality over the other; however, type B lesions are probably best treated with angioplasty while type C lesions may be best treated with surgery.